APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Protein Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Protein Service Market Outlook and Growth Opportunities 2026

16 January 2026192 pages

Choose your research edition.

Industry ResearchRecombinant Protein Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Protein Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Recombinant Protein Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Protein Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Protein Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Recombinant Protein Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Protein Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Protein Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Protein Service market include Sino Biological, Boster Bio, Proteos, ImmunoDiagnostics Limited, BiologicsCorp, GenScript, OriGene Technologies, R＆D Systems and Biomiga, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Recombinant Protein Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Protein Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Protein Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Recombinant Protein Service market.

Recombinant Protein Service Segment by Company

Sino Biological

Boster Bio

Proteos

ImmunoDiagnostics Limited

BiologicsCorp

GenScript

OriGene Technologies

R＆D Systems

Biomiga

Genemed

RayBiotech

BioServUK

Elabscienc

Jubilant Biosys

Recombinant Protein Service Segment by Type

Protein Purification

Protein Expression

Protein Modification And Processing

Other

Recombinant Protein Service Segment by Application

Antibody Production

Vaccine Production

Protein Pharmaceutical Production

Other

Recombinant Protein Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Protein Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Recombinant Protein Service key companies, revenue, market share, and recent developments.

3. To split the Recombinant Protein Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Recombinant Protein Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Protein Service significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Protein Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Protein Service industry.

Chapter 3: Detailed analysis of Recombinant Protein Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Recombinant Protein Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Recombinant Protein Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Protein Service Industry Trends Table 2. Recombinant Protein Service Industry Drivers Table 3. Recombinant Protein Service Industry Opportunities and Challenges Table 4. Recombinant Protein Service Industry Restraints Table 5. Global Recombinant Protein Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Protein Service Revenue Share by Company (2021-2026) Table 7. Global Recombinant Protein Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Recombinant Protein Service Key Company Manufacturing Base & Headquarters Table 9. Global Recombinant Protein Service Company, Product Type & Application Table 10. Global Recombinant Protein Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Recombinant Protein Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Protein Purification Table 15. Significant Companies of Protein Expression Table 16. Significant Companies of Protein Modification And Processing Table 17. Significant Companies of Other Table 18. Global Recombinant Protein Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Recombinant Protein Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Recombinant Protein Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Recombinant Protein Service Sales Value Share by Type (2021-2026) Table 22. Global Recombinant Protein Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Antibody Production Table 24. Significant Companies of Vaccine Production Table 25. Significant Companies of Protein Pharmaceutical Production Table 26. Significant Companies of Other Table 27. Global Recombinant Protein Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Recombinant Protein Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Recombinant Protein Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Recombinant Protein Service Sales Value Share by Application (2021-2026) Table 31. Global Recombinant Protein Service Sales Value Share by Application (2027-2032) Table 32. Global Recombinant Protein Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Recombinant Protein Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Recombinant Protein Service Sales Value Share by Region (2021-2026) Table 35. Global Recombinant Protein Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Recombinant Protein Service Sales Value Share by Region (2027-2032) Table 37. Global Recombinant Protein Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Recombinant Protein Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Recombinant Protein Service Sales Value Market Share by Country (2021-2026) Table 40. Global Recombinant Protein Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Recombinant Protein Service Sales Value Market Share by Country (2027-2032) Table 42. Sino Biological Company Information Table 43. Sino Biological Business Overview Table 44. Sino Biological Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sino Biological Recombinant Protein Service Product Portfolio Table 46. Sino Biological Recent Development Table 47. Boster Bio Company Information Table 48. Boster Bio Business Overview Table 49. Boster Bio Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Boster Bio Recombinant Protein Service Product Portfolio Table 51. Boster Bio Recent Development Table 52. Proteos Company Information Table 53. Proteos Business Overview Table 54. Proteos Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Proteos Recombinant Protein Service Product Portfolio Table 56. Proteos Recent Development Table 57. ImmunoDiagnostics Limited Company Information Table 58. ImmunoDiagnostics Limited Business Overview Table 59. ImmunoDiagnostics Limited Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio Table 61. ImmunoDiagnostics Limited Recent Development Table 62. BiologicsCorp Company Information Table 63. BiologicsCorp Business Overview Table 64. BiologicsCorp Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. BiologicsCorp Recombinant Protein Service Product Portfolio Table 66. BiologicsCorp Recent Development Table 67. GenScript Company Information Table 68. GenScript Business Overview Table 69. GenScript Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GenScript Recombinant Protein Service Product Portfolio Table 71. GenScript Recent Development Table 72. OriGene Technologies Company Information Table 73. OriGene Technologies Business Overview Table 74. OriGene Technologies Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. OriGene Technologies Recombinant Protein Service Product Portfolio Table 76. OriGene Technologies Recent Development Table 77. R＆D Systems Company Information Table 78. R＆D Systems Business Overview Table 79. R＆D Systems Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. R＆D Systems Recombinant Protein Service Product Portfolio Table 81. R＆D Systems Recent Development Table 82. Biomiga Company Information Table 83. Biomiga Business Overview Table 84. Biomiga Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Biomiga Recombinant Protein Service Product Portfolio Table 86. Biomiga Recent Development Table 87. Genemed Company Information Table 88. Genemed Business Overview Table 89. Genemed Recombinant Protein Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Genemed Recombinant Protein Service Product Portfolio Table 91. Genemed Recent Development Table 92. RayBiotech Company Information Table 93. RayBiotech Business Overview Table 94. RayBiotech Recombinant Protein Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. RayBiotech Recombinant Protein Service Product Portfolio Table 96. RayBiotech Recent Development Table 97. BioServUK Company Information Table 98. BioServUK Business Overview Table 99. BioServUK Recombinant Protein Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. BioServUK Recombinant Protein Service Product Portfolio Table 101. BioServUK Recent Development Table 102. Elabscienc Company Information Table 103. Elabscienc Business Overview Table 104. Elabscienc Recombinant Protein Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Elabscienc Recombinant Protein Service Product Portfolio Table 106. Elabscienc Recent Development Table 107. Jubilant Biosys Company Information Table 108. Jubilant Biosys Business Overview Table 109. Jubilant Biosys Recombinant Protein Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Jubilant Biosys Recombinant Protein Service Product Portfolio Table 111. Jubilant Biosys Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Recombinant Protein Service Product Image Figure 2. Global Recombinant Protein Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Protein Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Protein Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Protein Purification Image Figure 8. Protein Expression Image Figure 9. Protein Modification And Processing Image Figure 10. Other Image Figure 11. Global Recombinant Protein Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Recombinant Protein Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Protein Service Sales Value Share by Type (2021-2032) Figure 14. Antibody Production Image Figure 15. Vaccine Production Image Figure 16. Protein Pharmaceutical Production Image Figure 17. Other Image Figure 18. Global Recombinant Protein Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Recombinant Protein Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Recombinant Protein Service Sales Value Share by Application (2021-2032) Figure 21. Global Recombinant Protein Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Recombinant Protein Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Recombinant Protein Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Recombinant Protein Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Recombinant Protein Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Recombinant Protein Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Recombinant Protein Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Recombinant Protein Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Recombinant Protein Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Recombinant Protein Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Recombinant Protein Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Recombinant Protein Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Recombinant Protein Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Purification
  • Protein Expression
  • Protein Modification And Processing
  • Other
Applications
  • Antibody Production
  • Vaccine Production
  • Protein Pharmaceutical Production
  • Other
Companies covered
  • Sino Biological
  • Boster Bio
  • Proteos
  • ImmunoDiagnostics Limited
  • BiologicsCorp
  • GenScript
  • OriGene Technologies
  • R＆D Systems
  • Biomiga
  • Genemed
  • RayBiotech
  • BioServUK
  • Elabscienc
  • Jubilant Biosys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Protein Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Protein Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Recombinant Protein Service Market Dynamics
  1. 2.1 Recombinant Protein Service Industry Trends
  2. 2.2 Recombinant Protein Service Industry Drivers
  3. 2.3 Recombinant Protein Service Industry Opportunities and Challenges
  4. 2.4 Recombinant Protein Service Industry Restraints
3 Recombinant Protein Service Market by Company
  1. 3.1 Global Recombinant Protein Service Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Protein Service Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Protein Service Company Ranking (2024-2026)
  4. 3.4 Global Recombinant Protein Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Recombinant Protein Service Company Product Type and Application
  6. 3.6 Global Recombinant Protein Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Recombinant Protein Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Recombinant Protein Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Recombinant Protein Service Market by Type
  1. 4.1 Recombinant Protein Service Type Introduction
  2. 4.1.1 Protein Purification
  3. 4.1.2 Protein Expression
  4. 4.1.3 Protein Modification And Processing
  5. 4.1.4 Other
  6. 4.2 Global Recombinant Protein Service Sales Value by Type
  7. 4.2.1 Global Recombinant Protein Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Recombinant Protein Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Recombinant Protein Service Sales Value Share by Type (2021-2032)
5 Recombinant Protein Service Market by Application
  1. 5.1 Recombinant Protein Service Application Introduction
  2. 5.1.1 Antibody Production
  3. 5.1.2 Vaccine Production
  4. 5.1.3 Protein Pharmaceutical Production
  5. 5.1.4 Other
  6. 5.2 Global Recombinant Protein Service Sales Value by Application
  7. 5.2.1 Global Recombinant Protein Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Recombinant Protein Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Recombinant Protein Service Sales Value Share by Application (2021-2032)
6 Recombinant Protein Service Regional Value Analysis
  1. 6.1 Global Recombinant Protein Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Protein Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Recombinant Protein Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Recombinant Protein Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Protein Service Sales Value (2021-2032)
  7. 6.3.2 North America Recombinant Protein Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Recombinant Protein Service Sales Value (2021-2032)
  10. 6.4.2 Europe Recombinant Protein Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Recombinant Protein Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Recombinant Protein Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Recombinant Protein Service Sales Value (2021-2032)
  16. 6.6.2 South America Recombinant Protein Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Recombinant Protein Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Recombinant Protein Service Sales Value Share by Country, 2025 VS 2032
7 Recombinant Protein Service Country-level Value Analysis
  1. 7.1 Global Recombinant Protein Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Protein Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Recombinant Protein Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Recombinant Protein Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Recombinant Protein Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Recombinant Protein Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Recombinant Protein Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sino Biological
  2. 8.1.1 Sino Biological Company Information
  3. 8.1.2 Sino Biological Business Overview
  4. 8.1.3 Sino Biological Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sino Biological Recombinant Protein Service Product Portfolio
  6. 8.1.5 Sino Biological Recent Developments
  7. 8.2 Boster Bio
  8. 8.2.1 Boster Bio Company Information
  9. 8.2.2 Boster Bio Business Overview
  10. 8.2.3 Boster Bio Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boster Bio Recombinant Protein Service Product Portfolio
  12. 8.2.5 Boster Bio Recent Developments
  13. 8.3 Proteos
  14. 8.3.1 Proteos Company Information
  15. 8.3.2 Proteos Business Overview
  16. 8.3.3 Proteos Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Proteos Recombinant Protein Service Product Portfolio
  18. 8.3.5 Proteos Recent Developments
  19. 8.4 ImmunoDiagnostics Limited
  20. 8.4.1 ImmunoDiagnostics Limited Company Information
  21. 8.4.2 ImmunoDiagnostics Limited Business Overview
  22. 8.4.3 ImmunoDiagnostics Limited Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio
  24. 8.4.5 ImmunoDiagnostics Limited Recent Developments
  25. 8.5 BiologicsCorp
  26. 8.5.1 BiologicsCorp Company Information
  27. 8.5.2 BiologicsCorp Business Overview
  28. 8.5.3 BiologicsCorp Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BiologicsCorp Recombinant Protein Service Product Portfolio
  30. 8.5.5 BiologicsCorp Recent Developments
  31. 8.6 GenScript
  32. 8.6.1 GenScript Company Information
  33. 8.6.2 GenScript Business Overview
  34. 8.6.3 GenScript Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GenScript Recombinant Protein Service Product Portfolio
  36. 8.6.5 GenScript Recent Developments
  37. 8.7 OriGene Technologies
  38. 8.7.1 OriGene Technologies Company Information
  39. 8.7.2 OriGene Technologies Business Overview
  40. 8.7.3 OriGene Technologies Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OriGene Technologies Recombinant Protein Service Product Portfolio
  42. 8.7.5 OriGene Technologies Recent Developments
  43. 8.8 R＆D Systems
  44. 8.8.1 R＆D Systems Company Information
  45. 8.8.2 R＆D Systems Business Overview
  46. 8.8.3 R＆D Systems Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 R＆D Systems Recombinant Protein Service Product Portfolio
  48. 8.8.5 R＆D Systems Recent Developments
  49. 8.9 Biomiga
  50. 8.9.1 Biomiga Company Information
  51. 8.9.2 Biomiga Business Overview
  52. 8.9.3 Biomiga Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biomiga Recombinant Protein Service Product Portfolio
  54. 8.9.5 Biomiga Recent Developments
  55. 8.10 Genemed
  56. 8.10.1 Genemed Company Information
  57. 8.10.2 Genemed Business Overview
  58. 8.10.3 Genemed Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genemed Recombinant Protein Service Product Portfolio
  60. 8.10.5 Genemed Recent Developments
  61. 8.11 RayBiotech
  62. 8.11.1 RayBiotech Company Information
  63. 8.11.2 RayBiotech Business Overview
  64. 8.11.3 RayBiotech Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 RayBiotech Recombinant Protein Service Product Portfolio
  66. 8.11.5 RayBiotech Recent Developments
  67. 8.12 BioServUK
  68. 8.12.1 BioServUK Company Information
  69. 8.12.2 BioServUK Business Overview
  70. 8.12.3 BioServUK Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BioServUK Recombinant Protein Service Product Portfolio
  72. 8.12.5 BioServUK Recent Developments
  73. 8.13 Elabscienc
  74. 8.13.1 Elabscienc Company Information
  75. 8.13.2 Elabscienc Business Overview
  76. 8.13.3 Elabscienc Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Elabscienc Recombinant Protein Service Product Portfolio
  78. 8.13.5 Elabscienc Recent Developments
  79. 8.14 Jubilant Biosys
  80. 8.14.1 Jubilant Biosys Company Information
  81. 8.14.2 Jubilant Biosys Business Overview
  82. 8.14.3 Jubilant Biosys Recombinant Protein Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jubilant Biosys Recombinant Protein Service Product Portfolio
  84. 8.14.5 Jubilant Biosys Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst